BE408242A - - Google Patents
Info
- Publication number
- BE408242A BE408242A BE408242DA BE408242A BE 408242 A BE408242 A BE 408242A BE 408242D A BE408242D A BE 408242DA BE 408242 A BE408242 A BE 408242A
- Authority
- BE
- Belgium
- Prior art keywords
- serum
- specific
- albumin
- pepsin
- hydrochloric acid
- Prior art date
Links
- 210000002966 serum Anatomy 0.000 claims description 39
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 27
- 108010088751 Albumins Proteins 0.000 claims description 23
- 102000009027 Albumins Human genes 0.000 claims description 23
- 238000000034 method Methods 0.000 claims description 20
- 229940111202 pepsin Drugs 0.000 claims description 15
- 102000057297 Pepsin A Human genes 0.000 claims description 14
- 108090000284 Pepsin A Proteins 0.000 claims description 14
- 229960005486 vaccine Drugs 0.000 claims description 12
- 239000002244 precipitate Substances 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 6
- 210000000056 organ Anatomy 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 5
- 239000005862 Whey Substances 0.000 claims description 4
- 102000007544 Whey Proteins Human genes 0.000 claims description 4
- 108010046377 Whey Proteins Proteins 0.000 claims description 4
- 201000008827 tuberculosis Diseases 0.000 claims description 4
- 239000012530 fluid Substances 0.000 claims description 2
- 230000035876 healing Effects 0.000 claims description 2
- 201000009030 Carcinoma Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- 230000029087 digestion Effects 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 230000009931 harmful effect Effects 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 206010028980 Neoplasm Diseases 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 6
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 210000000936 intestine Anatomy 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000002458 infectious effect Effects 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 241000283086 Equidae Species 0.000 description 3
- 208000007502 anemia Diseases 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 206010000210 abortion Diseases 0.000 description 2
- 231100000176 abortion Toxicity 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 241000283707 Capra Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 241000282849 Ruminantia Species 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 238000009566 cancer vaccine Methods 0.000 description 1
- 229940022399 cancer vaccine Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 150000003355 serines Chemical class 0.000 description 1
- 206010040400 serum sickness Diseases 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/13—Tumour cells, irrespective of tissue of origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE408242A true BE408242A (ref) |
Family
ID=72856
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE408242D BE408242A (ref) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE408242A (ref) |
-
0
- BE BE408242D patent/BE408242A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2464068A1 (fr) | Compositions a base de dimethylsulfoxyde et leurs applications, notamment en therapeutique | |
| JP2003535020A (ja) | 治療用の抗真菌性爪用調製物 | |
| TW200911279A (en) | Compositions, uses, and method of making wound care products from naturally occurring food ingredients | |
| EP0117962A1 (fr) | Procédé de préparation de graisses peroxydées par transformation biologique à faible énergie, produits obtenus par ce procédé, mélanges de ces produits avec des additifs et nouveaux médicaments constitués de ces produits | |
| FR3055215A1 (fr) | Composition comprenant des extraits de pollen et /ou de pistils | |
| FR2843883A1 (fr) | Extraits de sangsues pour psoriasis | |
| FR2686251A1 (fr) | Composition pour la cicatrisation d'une plaie. | |
| RU2162352C1 (ru) | Способ лечения псориаза | |
| BE528932A (ref) | ||
| RU2781332C1 (ru) | Способ эндоскопического лечения химических ожогов пищевода | |
| US20030077257A1 (en) | Method for preventing and curing diseases of an immune system and a remedy for carrying out said method | |
| CN112353786A (zh) | 一种亚精胺及其复合物在制备肠道免疫功能增强剂中的应用 | |
| RU2146916C1 (ru) | Способ лечения детей, больных вторичным панкреатитом | |
| FR2500305A1 (fr) | Procede de preparation d'un extrait de sperme, extrait obtenu selon ce procede et son utilisation notamment en therapeutique et en cosmetique | |
| Vasey | Natural Remedies for Inflammation | |
| FR2693208A1 (fr) | Procédé d'obtention d'une composition enzymatique d'origine végétale ainsi que composition obtenue par la mise en Óoeuvre de ce procédé. | |
| Dixon | A Manual of pharmacology | |
| CN120478361A (zh) | N-[3-氯-4-({[2-(甲氨基)-6-(2-吡啶基)-4-嘧啶基]氨基}甲基)苯基]在治疗慢性萎缩性胃炎中的应用 | |
| Druitt | The Surgeon's Vade Mecum: a Hand-book of the Principles and Practice of Surgery... with... Wood Engravings | |
| AU771206B2 (en) | Side effects treatment | |
| BG99446A (bg) | Биологично активно средство,метод за получаването му и лекарствен препарат на неговата основа | |
| BE546837A (ref) | ||
| Bride | A REPORT ON TWO CASES OF DELAYED CHLOROFORM TOXÆMIA. | |
| JPH09505316A (ja) | 生産体としてのフサリウム菌類株の利用及びその適応原及び免疫変成効果を有する塩基に基づいた製法 | |
| Khalfallah | Influence de l'anesthésie sur quelques paramètres sanguins chez le loup d'élevage Dicentrarchus labrax L. 1758 |